Immunohistochemical findings related to EZH2 expression in colorectal cancers. Score 0 (negative), score 1 (weak), score 2 (moderate), and score 3 (strong) EZH2 expressions were observed in 11%, 21%, 18%, and 50% of the 109 colorectal cancer tissues, respectively. Five random high-power fields were evaluated per lesion to determine the mean nuclear positivity, which was categorized as follows: score 0 (negative, < 5%), score 1 (weak, 5%-39%), score 2 (moderate, 40%-79%), or score 3 (strong, ≥ 80%).
